Status:
RECRUITING
Mother-infant Microbiota Transmission and Its Link to the Health of the Baby
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Gut Microbiome
Mother to Child Transmission
Eligibility:
All Genders
Brief Summary
The human intestinal tract harbors a diverse and complex microbial community, known as gut microbiota, which is critical in sustaining physiology, metabolism, nutrition and immune function. Dysbiosis ...
Eligibility Criteria
Inclusion
- Pregnant women
- Being pregnant
- Plan to give birth in local hospital
- Competent to provide informed consent (no mental illness or dementia, etc. that will hinder their ability to undertake informed consent)
- Plan to stay in the same local area for at least 7 years post-delivery
Exclusion
- No
- New Born Baby Inclusion Criteria
- Be a new born baby of an enrolled pregnant woman
- One of the parents or legal guardian is competent to provide informed consent (no mental illness or dementia, etc. that will hinder their ability to undertake informed consent)
Key Trial Info
Start Date :
September 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 2 2027
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04117321
Start Date
September 23 2019
End Date
October 2 2027
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong, China